The present invention is directed to the combination therapy of an afucosylated anti-CD20 antibody specifically binding to a tumor-antigen with human IL-15 for the treatment of cancer.La présente invention concerne la plurithérapie dun anticorps anti-CD20 afucosylé se liant à un antigène tumoral avec lIL-15 humaine pour le traitement du cancer.